Northern Trust’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.76M Buy
1,784,126
+245,118
+16% +$241K ﹤0.01% 3065
2025
Q1
$2.22M Sell
1,539,008
-1,076
-0.1% -$1.55K ﹤0.01% 2870
2024
Q4
$3.39M Buy
1,540,084
+65,662
+4% +$144K ﹤0.01% 2739
2024
Q3
$2.43M Buy
1,474,422
+1,069,384
+264% +$1.76M ﹤0.01% 2878
2024
Q2
$899K Buy
405,038
+96,361
+31% +$214K ﹤0.01% 3297
2024
Q1
$827K Buy
308,677
+72,084
+30% +$193K ﹤0.01% 3392
2023
Q4
$707K Buy
236,593
+7,883
+3% +$23.6K ﹤0.01% 3427
2023
Q3
$224K Buy
228,710
+67,480
+42% +$66.1K ﹤0.01% 3767
2023
Q2
$224K Sell
161,230
-515,092
-76% -$716K ﹤0.01% 3784
2023
Q1
$1.08M Buy
676,322
+11,239
+2% +$17.9K ﹤0.01% 3196
2022
Q4
$4.14M Buy
665,083
+83,075
+14% +$518K ﹤0.01% 2600
2022
Q3
$3.9M Buy
582,008
+14,312
+3% +$95.9K ﹤0.01% 2639
2022
Q2
$3.61M Buy
567,696
+41,856
+8% +$266K ﹤0.01% 2714
2022
Q1
$2.44M Buy
525,840
+188,683
+56% +$876K ﹤0.01% 3003
2021
Q4
$1.69M Buy
337,157
+42,315
+14% +$212K ﹤0.01% 3309
2021
Q3
$3.55M Sell
294,842
-18,046
-6% -$217K ﹤0.01% 2952
2021
Q2
$6.62M Buy
312,888
+7,963
+3% +$168K ﹤0.01% 2656
2021
Q1
$8.55M Sell
304,925
-20,319
-6% -$570K ﹤0.01% 2396
2020
Q4
$8.46M Sell
325,244
-12,823
-4% -$333K ﹤0.01% 2362
2020
Q3
$12.6M Sell
338,067
-14,655
-4% -$545K ﹤0.01% 1958
2020
Q2
$18.1M Buy
352,722
+38,789
+12% +$1.99M ﹤0.01% 1703
2020
Q1
$9.9M Buy
313,933
+3,571
+1% +$113K ﹤0.01% 1875
2019
Q4
$18.5M Sell
310,362
-7,680
-2% -$458K ﹤0.01% 1784
2019
Q3
$11.7M Buy
318,042
+25,320
+9% +$928K ﹤0.01% 2045
2019
Q2
$13.6M Buy
292,722
+2,689
+0.9% +$125K ﹤0.01% 1951
2019
Q1
$11.6M Buy
290,033
+2,206
+0.8% +$88.6K ﹤0.01% 2050
2018
Q4
$13.2M Sell
287,827
-338,812
-54% -$15.6M ﹤0.01% 1887
2018
Q3
$27.8M Buy
626,639
+36,535
+6% +$1.62M 0.01% 1510
2018
Q2
$23.1M Buy
590,104
+10,702
+2% +$419K 0.01% 1672
2018
Q1
$41.9M Buy
579,402
+5,025
+0.9% +$363K 0.01% 1114
2017
Q4
$37.8M Sell
574,377
-3,540
-0.6% -$233K 0.01% 1221
2017
Q3
$29M Buy
577,917
+143,004
+33% +$7.17M 0.01% 1424
2017
Q2
$20.1M Sell
434,913
-88,697
-17% -$4.1M 0.01% 1667
2017
Q1
$18.5M Buy
523,610
+17,098
+3% +$604K 0.01% 1680
2016
Q4
$6.34M Buy
506,512
+2,137
+0.4% +$26.8K ﹤0.01% 2387
2016
Q3
$6.99M Buy
504,375
+168,489
+50% +$2.33M ﹤0.01% 2296
2016
Q2
$3.32M Buy
335,886
+144,373
+75% +$1.43M ﹤0.01% 2726
2016
Q1
$3.45M Buy
191,513
+6,361
+3% +$115K ﹤0.01% 2653
2015
Q4
$4.12M Buy
185,152
+4,728
+3% +$105K ﹤0.01% 2570
2015
Q3
$4.26M Buy
180,424
+78,379
+77% +$1.85M ﹤0.01% 2541
2015
Q2
$8.34M Buy
102,045
+30,811
+43% +$2.52M ﹤0.01% 2182
2015
Q1
$6.6M Buy
71,234
+4,020
+6% +$372K ﹤0.01% 2334
2014
Q4
$2.72M Buy
67,214
+16,372
+32% +$662K ﹤0.01% 2901
2014
Q3
$1.24M Sell
50,842
-1,692
-3% -$41.4K ﹤0.01% 3341
2014
Q2
$833K Sell
52,534
-6,444
-11% -$102K ﹤0.01% 3464
2014
Q1
$891K Sell
58,978
-5,020
-8% -$75.8K ﹤0.01% 3425
2013
Q4
$879K Buy
63,998
+43,483
+212% +$597K ﹤0.01% 3414
2013
Q3
$387K Buy
+20,515
New +$387K ﹤0.01% 3501